THE JOURNEYS OF PATIENTS WITH AUTOIMMUNE DISEASES DURING THE COVID-19 PANDEMIC
DOI:
https://doi.org/10.46827/ejphs.v8i1.209Keywords:
autoimmune diseases, COVID-19 pandemic, emotional resilience, coping mechanisms, holistic healthcareAbstract
This study explored the lived experiences of individuals with autoimmune diseases during the COVID-19 pandemic, uncovering their emotional struggles, challenges, coping mechanisms, and the broader implications of their condition amidst a global health crisis. Using a qualitative research approach, data were gathered through in-depth interviews with five participants from the Philippines, aged 20-70, and analyzed using Colaizzi’s method. Four central themes emerged: Emotional Struggles, Challenges, Adaptability, and Coping Mechanisms. Participants revealed that stress, anxiety, and fear were pervasive emotional stressors that exacerbated their autoimmune conditions. These struggles were compounded by challenges such as physical limitations, adherence to strict routines, and dietary restrictions, all intensified by the pandemic's restrictions and protocols. Despite these difficulties, participants demonstrated adaptability through changes in habits, adherence to medical regimens, and positive mindsets. Coping mechanisms were largely influenced by support systems, including family, friends, and healthcare providers, which played a crucial role in fostering resilience. The findings highlight the interplay between psychological, physical, and social dimensions in managing autoimmune diseases, particularly during a global health emergency. Recommendations include integrating mental health support into standard care, promoting telemedicine, fostering community support, and leveraging technology to enhance patient care. The study emphasizes the importance of holistic interventions and public health policies that address both the medical and emotional needs of individuals with autoimmune diseases. Future research should investigate the long-term impacts of the pandemic on this population to inform more comprehensive and sustainable healthcare strategies.
References
Ansarin, K., Taghizadeh, A., Safiri, S., Mahdavi, A. M., Ranjbar, S., Teymouri, S., Maleki, M. A., & Khabbazi, A. (2022). COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs. Annals of Rheumatic Diseases. Retrieved from https://ard.bmj.com/content/81/10/e190.
Bingham, K. S., Rozenbojm, N., Chong‐East, M., & Touma, Z. (2020). Exploring the mental health needs of persons with autoimmune diseases during the coronavirus disease 2019 pandemic: a proposed framework for future research and clinical care. ACR Open Rheumatology, 3(1), 25–33. https://doi.org/10.1002/acr2.11205.
Cleveland Clinic. (2019). Goiter | Cleveland Clinic. Cleveland Clinic. Retrieved from https://my.clevelandclinic.org/health/diseases/12625-goiter.
———. (2020). Graves’ Disease: Symptoms, Causes, Treatments & Tests. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/15244-graves-disease.
Gauge L. et al. (2020). Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review. Retrieved from: Retrieved from https://www.sciencedirect.com/science/article/pii/S0040595720301189.
Ketongole, S. P,. Bukuluki, P. (2021). The impact of COVID-19 on mental health of frontline health workers in Ghana and Uganda. Retrieved from: Retrieved from https://www.sciencedirect.com/topics/psychology/phenomenological-approach.
Khardori, R. (2019). Type 1 Diabetes Mellitus: Practice Essentials, Background, Pathophysiology. Medscape.com. Retrieved from https://emedicine.medscape.com/article/117739-overview.
Kim, Y., & Lee, H. (2020). Nurses’ experiences with disclosure of patient safety incidents: A qualitative study. Risk Management and Healthcare Policy, Volume 13, 453–464. https://doi.org/10.2147/rmhp.s253399.
Mayo Clinic. (2022). Lupus - Symptoms and Causes. Mayo Clinic. Retrieved from https://www.mayoclinic.org/diseases-conditions/lupus/symptoms-causes/syc-20365789.
Morrow, Rosie, Rodriguez, Alison and King, Nigel (2015). Colaizzi’s descriptive phenomenological method. The Psychologist, 28 (8). pp. 643-644. ISSN 0952-8229 Retrieved from https://eprints.hud.ac.uk/id/eprint/26984/1.
Psoriasis. (2019). CDC. Retrieved from https://www.cdc.gov/psoriasis/index.htm.
Robinson, P.C., Bursle, E.C. (2020). Management of autoimmune disease during the COVID-19 pandemic. NPS Medicinewise. https://www.nps.org.au/australian-prescriber/articles/management-of-autoimmune-disease-during-the-covid-19-pandemic#article.
Sylviana Hamdani (2021). Living with autoimmune disease during COVID-19 pandemic: A review retrieved from: https://www.thejakartapost.com/life/2021/07/29/living-with-autoimmune-disease-during-covid-19-pandemic.html.
Tan, E. H., Sena, et al. (2021). COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology, 60(SI), SI37–SI50. https://doi.org/10.1093/rheumatology/keab250.
Tan, E., et al. (2021) COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries, Rheumatology, Volume 60, Issue SI, pages SI37–SI50, https://doi.org/10.1093/rheumatology/keab250
The Canadian Press. (2022). Long COVID-19 linked with autoimmune diseases, Canadian study shows. Global News. https://globalnews.ca/news/9147833/long-covid-autoimmune-diseases-canadian-study/.
Wang, F. et al. (2022). Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis. Clin Rheumatol 41, 2213–2223 (2022). https://doi.org/10.1007/s10067-022-06087-1.
WHO Coronavirus (Covid-19) dashboard. (n.d.). WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Retrieved from https://data.who.int/dashboards/covid19/vaccines
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
